Rinsada for Dry Eye
(RINSE-A Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new treatment called Rinsada to determine its effectiveness in reducing inflammation that contributes to dry eye. Researchers will treat one eye with Rinsada while leaving the other eye untreated to compare the effects. Individuals who test positive for MMP-9 in both eyes, a marker linked to inflammation, may be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to groundbreaking research in dry eye treatment.
Will I have to stop taking my current medications?
If you are currently using topical anti-inflammatory medications like corticosteroids, cyclosporine, lifitegrast, or topical NSAIDs, you will need to stop them 14-30 days before joining the trial. The trial does not specify about other medications, so it's best to discuss with the trial team.
Is there any evidence suggesting that Rinsada is likely to be safe for humans?
Research shows that Rinsada is generally well-tolerated. In earlier studies, researchers found no major safety issues. Specifically, over 70% of patients experienced improvements without serious side effects. The treatment works by washing the eye surface to remove irritants and debris, which helps reduce swelling.
Some evidence suggests that Rinsada remains safe even with regular use for 3 to 6 months, as users did not report serious side effects during this period. While individual experiences can vary, the data so far indicates that Rinsada is a safe option for those dealing with dry eye symptoms.12345Why are researchers excited about this trial?
Most treatments for dry eye, like artificial tears, lubricating ointments, or anti-inflammatory drops, mainly focus on providing temporary relief or reducing inflammation. But Rinsada is unique because it targets the underlying causes of dry eye with a novel mechanism of action. Researchers are excited about Rinsada because it promises a more sustained improvement in eye moisture levels, which could mean longer-lasting relief for patients. This innovative approach could change the game for those suffering from persistent dry eye symptoms.
What evidence suggests that Rinsada might be an effective treatment for dry eye?
Research has shown that Rinsada can significantly reduce eye inflammation by lowering MMP-9, a substance linked to inflammation. This reduction can reach up to 70% shortly after treatment. Patients often experience less discomfort and clearer vision within hours of using Rinsada. In this trial, participants will receive Rinsada treatment in one eye, while the other eye serves as a control. The device thoroughly cleans the eye's surface, helping to stabilize the tear layer and potentially enhancing the effectiveness of other treatments. Overall, Rinsada presents a promising option for those with dry eye symptoms.12467
Are You a Good Fit for This Trial?
This trial is for people diagnosed with dry eye disease. Specific inclusion and exclusion criteria are not listed, but generally participants should have symptoms of dry eyes and be able to follow study procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ocular surface rinsing to reduce inflammation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Rinsada
Trial Overview
The study is testing whether rinsing parts of the eye (the inner eyelid and surrounding areas) can reduce inflammation and improve symptoms in people with dry eye disease.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rinsada
Lead Sponsor
Citations
The efficacy of an irrigating eyelid retractor-facilitated ocular ...
At 3 hours post-rinse, there was a statistically significant reduction in MMP-9 by complete ocular irrigation facilitated by an irrigating ...
2.
glance.eyesoneyecare.com
glance.eyesoneyecare.com/stories/2024-04-11/rinsada-s-irrigating-eyelid-retractor-targets-ocular-surface-restoration/Rinsada's irrigating eyelid retractor targets ocular surface ...
the device was shown to “statistically reduce improve patient symptoms” at 3 hours post-rinse. Further, a >70% reduction in MMP-9 and over 40% ...
3.
eyesymmetryvision.com
eyesymmetryvision.com/dry-eye-optometrist/dry-eye-treatments/rinsada-for-lasting-dry-eye-relief/RINSADA® for Lasting Dry Eye Relief
Clinical studies have shown significant reductions in the inflammatory marker MMP-9. They also reported notable improvements in patient symptoms, proving its ...
Dry Eye Disease (Keratoconjunctivitis Sicca) Treatment & ...
At Day 21, noted as early in the trial, statistically significant improvement in 4 symptoms and 3 ocular signs were observed when cyclosporine 1 ...
Recalcitrant Dry Eye Disease in a 31-Year-Old Female
This report explores the management of an otherwise healthy 31-year-old Caucasian female with chronic, refractory dry eye disease (DED) ...
Home — rinsada--irrigating lid retractor
Rinsada is the safe, natural and most thorough way to treat an irritated eye, flush away impurities and clean the entire ocular surface – even underneath ...
Keratoconjunctivitis Sicca - Eye Disorders
Keratoconjunctivitis sicca is dryness of the conjunctiva (the membrane that lines the eyelids and covers the white of the eye) and cornea.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.